273 related articles for article (PubMed ID: 32743746)
1. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues.
Nervo A; Ragni A; Retta F; Gallo M; Piovesan A; Liberini V; Gatti M; Ricardi U; Deandreis D; Arvat E
J Endocrinol Invest; 2021 Mar; 44(3):403-419. PubMed ID: 32743746
[TBL] [Abstract][Full Text] [Related]
2. Improved Survival After Multimodal Approach with
Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2019 Jul; 29(7):971-978. PubMed ID: 31017051
[No Abstract] [Full Text] [Related]
3. Approach to the thyroid cancer patient with extracervical metastases.
Haugen BR; Kane MA
J Clin Endocrinol Metab; 2010 Mar; 95(3):987-93. PubMed ID: 20203334
[TBL] [Abstract][Full Text] [Related]
4. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.
Mazziotti G; Formenti AM; Panarotto MB; Arvat E; Chiti A; Cuocolo A; Dottorini ME; Durante C; Agate L; Filetti S; Felicetti F; Filice A; Pace L; Pellegrino T; Rodari M; Salvatori M; Tranfaglia C; Versari A; Viola D; Frara S; Berruti A; Giustina A; Giubbini R
Endocrine; 2018 Jan; 59(1):90-101. PubMed ID: 29110129
[TBL] [Abstract][Full Text] [Related]
5. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract][Full Text] [Related]
6. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
[No Abstract] [Full Text] [Related]
7. Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine-resistant differentiated thyroid cancer.
Navarro-Gonzalez E
Cancer Med; 2022 Oct; 11 Suppl 1(Suppl 1):54-58. PubMed ID: 35785524
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.
Song HJ; Wu CG; Xue YL; Xu YH; Qiu ZL; Luo QY
Clin Nucl Med; 2012 Jun; 37(6):e129-33. PubMed ID: 22614210
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
11. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.
Bernier MO; Leenhardt L; Hoang C; Aurengo A; Mary JY; Menegaux F; Enkaoua E; Turpin G; Chiras J; Saillant G; Hejblum G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1568-73. PubMed ID: 11297585
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases from differentiated thyroid carcinoma.
Muresan MM; Olivier P; Leclère J; Sirveaux F; Brunaud L; Klein M; Zarnegar R; Weryha G
Endocr Relat Cancer; 2008 Mar; 15(1):37-49. PubMed ID: 18310274
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
14. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases.
Nakayama R; Horiuchi K; Susa M; Watanabe I; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Morioka H
Jpn J Clin Oncol; 2014 Oct; 44(10):918-25. PubMed ID: 25104791
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prognosis for patients with differentiated thyroid carcinoma bone metastases.
Wang S; Luo J; Zhong Z; Qi X; Liu T; Qin R; Zhao Z; Xi Y; Sun R; Wu Y; Sun C
Transl Cancer Res; 2020 Feb; 9(2):972-982. PubMed ID: 35117442
[TBL] [Abstract][Full Text] [Related]
17. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
Qiu ZL; Shen CT; Luo QY
Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
J Clin Endocrinol Metab; 2020 Mar; 105(3):e457-65. PubMed ID: 31665318
[TBL] [Abstract][Full Text] [Related]
19. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer.
Ishigaki T; Uruno T; Sugino K; Masaki C; Akaishi J; Hames KY; Suzuki A; Tomoda C; Matsuzu K; Ohkuwa K; Kitagawa W; Nagahama M; Miyazaki S; Ito K
J Radiat Res; 2019 Nov; 60(6):831-836. PubMed ID: 31423531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
